FFA
ABCL icon

Farther Finance Advisors’s AbCellera Biologics ABCL Stock Holding History

Farther Finance Advisors’s Portfolio ABCL Stock Details ABCL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$58.4K Hold
16,645
– – ﹤0.01% 2885
2025
Q4 		$56.9K Hold
16,645
– – ﹤0.01% 2727
2025
Q3 		$83.7K Buy
16,645
+752
+5% +$3.31K ﹤0.01% 2141
2025
Q2 		$54.5K Hold
15,893
– – ﹤0.01% 2097
2025
Q1 		$33.2K Hold
15,893
– – ﹤0.01% 2115
2024
Q4 		$46.6K Sell
15,893
-606
-4% -$1.69K ﹤0.01% 1698
2024
Q3 		$42.9K Buy
16,499
+1,487
+10% +$4.12K ﹤0.01% 1737
2024
Q2 		$41.7K Hold
15,012
– – ﹤0.01% 1495
2024
Q1 		$66.7K Buy
15,012
+5,000
+50% +$25.5K ﹤0.01% 1087
2023
Q4 		$57.2K Buy
+10,012
New +$46.4K ﹤0.01% 991

Other funds holding ABCL

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $121B AUM 33.93% 1-Year Est. Return
TWC
TD Waterhouse Canada Toronto, Ontario, Canada $33.7B AUM 35.49% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $564B AUM 30.12% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $761B AUM 31.28% 1-Year Est. Return